Claude Knopf

Claude Knopf is a highly accomplished professional with a diverse educational background and extensive experience in business development, licensing, mergers and acquisitions in the pharmaceutical industry.

Knopf holds a Bachelor of Arts in Economics from Manchester College, an International MBA from the University of South Carolina, and has completed executive education programs at prestigious institutions such as Wharton Business School, Harvard Business School, and Tufts University.

With a strong foundation in economics and business management, Knopf has held key leadership positions in renowned organizations. Notably, he has served as the Chief Business Officer at Imcheck Therapeutics and held similar roles at Gemini Therapeutics and Pieris Pharmaceuticals.

His professional journey includes senior roles at leading pharmaceutical companies like Novartis and Baxalta - Baxter Bioscience, where he oversaw global business development, licensing, and strategic planning initiatives. Knopf has also managed alliances and brand activities for major pharmaceutical products.

Additionally, Knopf has a background in finance and audit management, having served as a Senior Internal Audit Manager at Merck and as a Financial Director for a plant in Turkey at Valeo.

Claude Knopf's expertise covers a wide range of areas including mergers and acquisitions, negotiation strategies, clinical development, and alliance management. His strategic vision and business acumen have been instrumental in driving growth and innovation within the pharmaceutical sector.